NCT01396057 Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO) Status COMPLETED Phase PHASE3
NCT01377597 Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion Status COMPLETED Phase PHASE3
NCT01363570 Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes Status COMPLETED Phase NA
NCT01325181 Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy Status COMPLETED Phase PHASE1/PHASE2
NCT01318941 Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting Status COMPLETED Phase N/A
NCT01315275 A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema Status COMPLETED Phase PHASE4
NCT01306981 Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study Status COMPLETED Phase PHASE4
NCT01292798 Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab Status COMPLETED Phase PHASE1/PHASE2
NCT01277302 A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion Status COMPLETED Phase PHASE4
NCT01257815 Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment Status COMPLETED Phase PHASE4
NCT01256632 Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy Status COMPLETED Phase NA
NCT01255774 Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy Status UNKNOWN Phase PHASE3
NCT01249937 Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab Status UNKNOWN Phase PHASE2
NCT01247220 REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study Status COMPLETED Phase PHASE2
NCT01243086 OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab Status COMPLETED Phase PHASE2
NCT01225146 Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2) Status TERMINATED Phase PHASE1
NCT01223612 Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation Status COMPLETED Phase PHASE4
NCT01217944 Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia Status COMPLETED Phase PHASE3
NCT01213667 Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD Status UNKNOWN Phase PHASE4